Qualitative or quantitative defects of collagen 6

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:207090
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Qualitative or quantitative defects of collagen 6 encompass a spectrum of inherited muscle disorders caused by mutations in the genes encoding collagen VI (COL6A1, COL6A2, and COL6A3). Collagen VI is a major structural component of the extracellular matrix surrounding muscle fibers, tendons, skin, and other connective tissues. When collagen VI is either reduced in quantity (quantitative defect) or structurally abnormal (qualitative defect), it leads to a range of clinical conditions collectively known as collagen VI-related myopathies. The most recognized conditions within this spectrum include Ullrich congenital muscular dystrophy (UCMD) at the severe end, Bethlem myopathy at the milder end, and an intermediate phenotype bridging the two. The primary body systems affected are the musculoskeletal and connective tissue systems. Key clinical features include progressive muscle weakness, joint contractures (particularly of the elbows, ankles, and fingers), and proximal joint hyperlaxity (especially of the wrists and fingers), which is a distinctive hallmark. Patients may also experience skin abnormalities such as soft, velvety skin, keloidal scarring, and follicular hyperkeratosis. In more severe forms such as UCMD, respiratory insufficiency can develop early and may require ventilatory support. Bethlem myopathy typically presents with a milder, slowly progressive course, though contractures and mild respiratory compromise can still occur over time. Currently, there is no curative treatment for collagen VI-related myopathies. Management is supportive and multidisciplinary, focusing on physical therapy to maintain mobility and manage contractures, respiratory monitoring and intervention when needed, and orthopedic management. Research into potential therapies, including approaches to enhance collagen VI production or correct underlying defects through gene therapy, is ongoing but remains largely experimental.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Qualitative or quantitative defects of collagen 6.

View clinical trials →

No actively recruiting trials found for Qualitative or quantitative defects of collagen 6 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Qualitative or quantitative defects of collagen 6 community →

No specialists are currently listed for Qualitative or quantitative defects of collagen 6.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Qualitative or quantitative defects of collagen 6.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Qualitative or quantitative defects of collagen 6Forum →

No community posts yet. Be the first to share your experience with Qualitative or quantitative defects of collagen 6.

Start the conversation →

Latest news about Qualitative or quantitative defects of collagen 6

No recent news articles for Qualitative or quantitative defects of collagen 6.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Qualitative or quantitative defects of collagen 6

What is Qualitative or quantitative defects of collagen 6?

Qualitative or quantitative defects of collagen 6 encompass a spectrum of inherited muscle disorders caused by mutations in the genes encoding collagen VI (COL6A1, COL6A2, and COL6A3). Collagen VI is a major structural component of the extracellular matrix surrounding muscle fibers, tendons, skin, and other connective tissues. When collagen VI is either reduced in quantity (quantitative defect) or structurally abnormal (qualitative defect), it leads to a range of clinical conditions collectively known as collagen VI-related myopathies. The most recognized conditions within this spectrum includ